智造驱动创意落地 本届上交会展览面积达3.5万平方米，科技含量与产业价值齐升。 作为一家以智能科技为核心驱动力的创新型企业，上海秀美模型有限公司专注于三维建模、动态模拟与动画制作，依托3D打印、智能集成与多媒体交 互等先进技术，打造沉浸式虚拟展厅、智能化教学空间等多场景解决方案，展现了"所见即所得"的科技魅力。 据悉，公司的服务范围覆盖海洋经济、教育科研、工业智造等多个板块，不仅为政府、高校、企业等提供一站式项目支持，更在船舶模型智能制造领域 内引领风向。此次亮相上交会，秀美展示了其在虚拟仿真、智能制造与个性化服务定制方面的最新成果。 以"开放合作：赋能新质生产力与可持续发展"为主题，第十一届中国（上海）国际技术进出口交易会（下称"上交会"）近日召开。这场专注于技术贸易 的国家级展会，汇聚了近千家中外企业，覆盖航天航空、海洋工程、智能制造、绿色能源、区块链等多个领域，集中呈现一批"首展首发"技术与应用场景， 成为中国面向全球展示科技创新能力和技术合作成果的重要窗口。 在数字中国与信息强国战略加速推进的背景下，计算芯片作为核心算力支撑，其安全性、性能和生态兼容能力正成为国家数字基础设施建设的关键指 标。 成立于 ...

当前，实验室建设已成为国家科技创新体系的核心载体。2025年政府工作报告明确提出加强概念验证、中试验 证和行业共性技术平台建设，并将实验室作为 "强化企业主导的产学研深度融合" 的重要抓手。 近日，SLD中检和河北清华发展研究院，达成了实验室项目设计合作，其设计方案结合CNAS实验室认可评审 要求和实验室相关设计规范，助力打造集科研、转化、验证于一体的高标准创新平台，为京津冀协同发展注入 新动能。 政策赋能与产业需求的双向驱动 概念验证平台实验室的建设，正是响应河北省《基础研究计划概念验证项目实施方案》的重要举措，该方案明 确提出通过资金支持、基金对接等方式，加速前沿技术从 "实验室" 到 "产业化" 的转化。 企业关系： 优势互补的产学研协同典范。 研究院相关负责人表示，此次合作将充分发挥 SLD中检在实验室规划、工艺设计等方面的专业优势，为清华大 学及河北本地科研团队提供从技术验证到产业孵化的全链条支撑，推动更多 "硬科技" 成果在石家庄落地生 根。 智能绿色实验室赋能河北创新发展 在此背景下，河北清华发展研究院与 SLD中检的合作具有双重战略意义： 政策契合性： 项目响应国家 "十四五" 实验室建设规划 ...

Financial Data and Key Metrics Changes - LabCorp reported exceptional results in 2024, with strong momentum heading into 2025, indicating a positive outlook for financial performance [4] - At least 91% of shares voted in favor of the nonbinding advisory approval of the company's compensation for named executive officers, reflecting shareholder confidence [30] - The approval rate for the company's 2025 omnibus incentive plan was at least 94%, and for the employee stock purchase plan, it was at least 99% [30] Business Line Data and Key Metrics Changes - The diagnostics and biopharma laboratory services businesses made meaningful advances through organic growth and transformative acquisitions, contributing to the overall success of LabCorp [4] Market Data and Key Metrics Changes - No specific market data or key metrics changes were provided in the meeting [0] Company Strategy and Development Direction - LabCorp is focused on improving health and lives while generating attractive returns for shareholders, positioning itself well for future growth [4] - The company emphasizes ethical and regulatory responsibilities in its biopharma laboratory services, particularly regarding animal welfare and research integrity [35] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in LabCorp's positioning for continued success in 2025, highlighting the importance of their strategic initiatives [4] - The company is committed to high standards of animal care and welfare, which is fundamental to sound scientific research [35] Other Important Information - The meeting included the election of directors, approval of executive compensation, and ratification of the independent registered public accounting firm for 2025, all of which passed with significant support from shareholders [30] Q&A Session Summary Question: What specific measures is LabCorp taking to mitigate biosafety and public health risks associated with research animals? - LabCorp takes its ethical and regulatory responsibilities seriously, ensuring the health and wellness of research animals, which is fundamental to scientific research [35] - The company has a dedicated global team to establish high standards of animal care and welfare, proactively identifying and mitigating risks [36]